133 related articles for article (PubMed ID: 2545973)
1. Alternating methotrexate and dactinomycin in nonmetastatic gestational trophoblastic disease.
Rose PG; Piver MS
J Surg Oncol; 1989 Jul; 41(3):148-52. PubMed ID: 2545973
[TBL] [Abstract][Full Text] [Related]
2. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy.
Roberts JP; Lurain JR
Am J Obstet Gynecol; 1996 Jun; 174(6):1917-23; discussion 1923-4. PubMed ID: 8678159
[TBL] [Abstract][Full Text] [Related]
3. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid.
Gleeson NC; Finan MA; Fiorica JV; Robert WS; Hoffman MS; Wilson J
Eur J Gynaecol Oncol; 1993; 14(6):461-5. PubMed ID: 7514124
[TBL] [Abstract][Full Text] [Related]
4. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
5. Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate--folinic acid.
Smith EB; Weed JC; Tyrey L; Hammond CB
Am J Obstet Gynecol; 1982 Sep; 144(1):88-92. PubMed ID: 6287843
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of trophoblastic disease].
Nechaeva ID; Semenovskiĭ AV
Vopr Onkol; 1976; 22(5):85-92. PubMed ID: 180685
[No Abstract] [Full Text] [Related]
7. Treatment of nonmetastatic gestational trophoblastic disease with sequential intramuscular and oral methotrexate.
Barter JF; Soong SJ; Hatch KD; Orr JW; Partridge EC; Austin JM; Shingleton HM
Gynecol Oncol; 1989 Apr; 33(1):82-4. PubMed ID: 2467846
[TBL] [Abstract][Full Text] [Related]
8. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
9. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
Homesley HD; Blessing JA; Rettenmaier M; Capizzi RL; Major FJ; Twiggs LB
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):413-8. PubMed ID: 2457192
[TBL] [Abstract][Full Text] [Related]
10. Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1998 Jan; 43(1):69-74. PubMed ID: 9475152
[TBL] [Abstract][Full Text] [Related]
11. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities.
Matsui H; Iitsuka Y; Seki K; Sekiya S
Gynecol Obstet Invest; 1998; 46(1):5-8. PubMed ID: 9692333
[TBL] [Abstract][Full Text] [Related]
12. Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use.
Kohorn EI
J Reprod Med; 1991 Jan; 36(1):49-55. PubMed ID: 1848901
[TBL] [Abstract][Full Text] [Related]
13. Malignant trophoblastic neoplasia. Monitoring of therapy.
Kolstad P; Hoeg K; Norman N
Acta Obstet Gynecol Scand; 1972; 51(3):275-81. PubMed ID: 4342019
[No Abstract] [Full Text] [Related]
14. Pregnancy after chemotherapy for gestational trophoblastic disease.
Ayhan A; Ergeneli MH; Yüce K; Yapar EG; Kişnişçi AH
J Reprod Med; 1990 May; 35(5):522-4. PubMed ID: 2161928
[TBL] [Abstract][Full Text] [Related]
15. Pulse actinomycin D scheduling in nonmetastatic gestational trophoblastic neoplasia: cost-effective chemotherapy.
Twiggs LB
Gynecol Oncol; 1983 Oct; 16(2):190-5. PubMed ID: 6313493
[TBL] [Abstract][Full Text] [Related]
16. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Surwit EA; Childers JM
J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900
[TBL] [Abstract][Full Text] [Related]
17. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
Dobson LS; Lorigan PC; Coleman RE; Hancock BW
Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722
[TBL] [Abstract][Full Text] [Related]
18. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.
Kwon JS; Elit L; Mazurka J; Moens F; Schmuck ML
Gynecol Oncol; 2001 Aug; 82(2):367-70. PubMed ID: 11531296
[TBL] [Abstract][Full Text] [Related]
19. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
20. First line chemotherapy in low risk gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Hancock BW; Osborne R
Cochrane Database Syst Rev; 2009 Jan; (1):CD007102. PubMed ID: 19160319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
